NCT05142592 2025-09-24
Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors
Nanjing Immunophage Biotech Co., Ltd
Phase 1/2 Recruiting
Nanjing Immunophage Biotech Co., Ltd
Cancer Institute and Hospital, Chinese Academy of Medical Sciences